Skip to main content
. 2009 Apr 15;29(15):4964–4971. doi: 10.1523/JNEUROSCI.4560-08.2009

Figure 4.

Figure 4.

CD 45 expression is reduced after 6 months of systemic anti-Aβ antibody administration and these reductions are maintained 3 months after the cessation of treatment. A and B show CD 45 immunoreactivity in the frontal cortex of Tg2576 mice that received control antibody at 14 months of age and at 17 months of age, respectively. C and D show CD 45 immunoreactivity in Tg2576 mice that received anti-Aβ antibody at 14 months of age and at 17 months of age. Scale bar, 120 μm.